Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.
about
Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaPruritus in patients treated with targeted cancer therapies: systematic review and meta-analysisImatinib-based therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: A case report and literature reviewMulticenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib.Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment.Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.Durable remission in a patient of mixed phenotype acute leukemia with Philadelphia chromosome-positive treated with nilotinib and lenalidomide: A case report.A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia.
P2860
Q27025242-FA31DF54-BDCD-4BB0-B541-739E353299A6Q34272887-8447223D-0419-470E-8216-24ED884D38CDQ36085424-7DFE3BB3-E96F-49E4-8747-B6A6CCBCE2F3Q37714981-226BE263-EFBE-47C2-AC47-A6A57D582B01Q48275281-5AD4FE82-7092-4CCC-AA2C-21705F5BF838Q51160378-0E9C92B9-D866-48AF-9D15-3AB3432CEF91Q52604951-3EEA7F29-9BD2-4CD4-9FD3-BAF7E231E836Q53659325-239459D4-917D-48C7-B995-F59095DF8C75
P2860
Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@ast
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@en
type
label
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@ast
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@en
prefLabel
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@ast
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@en
P2093
P2860
P1476
Efficacy and safety of nilotin ...... sis of a phase I and II study.
@en
P2093
Aira Wanajo
Akira Matsuda
Arinobu Tojo
Chiaki Nakaseko
Hideo Tanaka
Kenji Oritani
Kensuke Usuki
Koichi Miyamura
Masaya Okada
Noriko Usui
P2860
P2888
P304
P356
10.1007/S12185-012-1026-9
P577
2012-02-23T00:00:00Z
P5875
P6179
1001935083